Literature DB >> 1709248

Low-dose aprotinin for reduction of blood loss after cardiopulmonary bypass.

C Vandenvelde, P Fondu, J Dubois-Primo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1709248     DOI： 10.1016/0140-6736(91)92821-i

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

Review 1.  Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.

Authors:  R Davis; R Whittington
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

2.  Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients.

Authors:  J F Hardy; J Desroches; S Belisle; J Perrault; M Carrier; D Robitaille
Journal:  Can J Anaesth       Date:  1993-07       Impact factor: 5.063
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.